Vitamin D Intake, Blood 25(OH)D Levels, and Breast Cancer Risk or Mortality: a Meta-analysis

Overview

Journal Br J Cancer

Specialty Oncology

Date 2014 Apr 10

PMID 24714744

Citations 89

Authors

Y Kim

Y Je

Affiliations

Soon will be listed here.

Abstract

Background: Experimental studies suggest potential anti-carcinogenic properties of vitamin D against breast cancer risk, but the epidemiological evidence to date is inconsistent.

Methods: We searched MEDLINE and EMBASE databases along with a hand search for eligible studies to examine the association between vitamin D status (based on diet and blood 25-hydroxyvitamin D (25(OH)D)) and breast cancer risk or mortality in a meta-analysis. A random-effect model was used to calculate a pooled adjusted relative risk (RR).

Results: A total of 30 prospective studies (nested case-control or cohort) were included for breast cancer incidence (n=24 studies; 31 867 cases) or mortality (n=6 studies; 870 deaths) among 6092 breast cancer patients. The pooled RRs of breast cancer incidence for the highest vs the lowest vitamin D intake and blood 25(OH)D levels were 0.95 (95% CI: 0.88-1.01) and 0.92 (95% CI: 0.83-1.02), respectively. Among breast cancer patients, high blood 25(OH)D levels were significantly associated with lower breast cancer mortality (pooled RR=0.58, 95% CI: 0.40-0.85) and overall mortality (pooled RR=0.61, 95% CI: 0.48-0.79). There was no evidence of heterogeneity and publication bias.

Conclusions: Our findings suggest that high vitamin D status is weakly associated with low breast cancer risk but strongly associated with better breast cancer survival.

Citing Articles

Dietary Interventions for Breast Cancer Prevention: Exploring the Role of Nutrition in Primary and Tertiary Prevention Strategies.

Pontillo M, Trio R, Rocco N, Cinquerrui A, Di Lorenzo M, Catanuto G Healthcare (Basel). 2025; 13(4).

PMID: 39997282 PMC: 11854917. DOI: 10.3390/healthcare13040407.

Nutrition Modulation of Cardiotoxicity in Breast Cancer: A Scoping Review.

Stephenson E, Mclaughlin M, Bray J, Saxton J, Vince R Nutrients. 2024; 16(21).

PMID: 39519610 PMC: 11547447. DOI: 10.3390/nu16213777.

Integrated evaluation of workplace exposures and biomarkers of bladder cancer among textile dyeing workers.

Saad-Hussein A, Beshir S, Shaheen W, Saleh I, Elhamshary M, Mohammed A J Egypt Public Health Assoc. 2024; 99(1):23.

PMID: 39285014 PMC: 11405732. DOI: 10.1186/s42506-024-00167-7.

Umbrella Review on the Relationship between Vitamin D Levels and Cancer.

Schomann-Finck M, Reichrath J Nutrients. 2024; 16(16).

PMID: 39203855 PMC: 11356988. DOI: 10.3390/nu16162720.

Altered liver metabolism post-wean abolishes efficacy of vitamin D for breast cancer prevention in a mouse model.

Bernhardt S, Ozaki M, Betts C, Bleyle L, DeBarber A, Fornetti J bioRxiv. 2024; .

PMID: 38854129 PMC: 11160686. DOI: 10.1101/2024.05.28.596304.

References

Wu Y, Zhang D, Kang S . Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2013; 137(3):869-82. DOI: 10.1007/s10549-012-2396-7. View

Zehnder D, Bland R, Williams M, McNinch R, Howie A, Stewart P . Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001; 86(2):888-94. DOI: 10.1210/jcem.86.2.7220. View

Chlebowski R, Johnson K, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T . Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008; 100(22):1581-91. PMC: 2673920. DOI: 10.1093/jnci/djn360. View

Sundaram S, Sea A, Feldman S, Strawbridge R, Hoopes P, Demidenko E . The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res. 2003; 9(6):2350-6. View

Wang D, DuBois R . Cyclooxygenase-2: a potential target in breast cancer. Semin Oncol. 2004; 31(1 Suppl 3):64-73. DOI: 10.1053/j.seminoncol.2004.01.008. View

Sperati F, Vici P, Maugeri-Sacca M, Stranges S, Santesso N, Mariani L . Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PLoS One. 2013; 8(7):e69269. PMC: 3718745. DOI: 10.1371/journal.pone.0069269. View

Edvardsen K, Veierod M, Brustad M, Braaten T, Engelsen O, Lund E . Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk. Int J Cancer. 2010; 128(6):1425-33. DOI: 10.1002/ijc.25463. View

Tirona M, Sehgal R, Ballester O . Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools. Cancer Invest. 2010; 28(7):743-50. DOI: 10.3109/07357907.2010.494321. View

Steindorf K, Ritte R, Eomois P, Lukanova A, Tjonneland A, Johnsen N . Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition. Int J Cancer. 2012; 132(7):1667-78. DOI: 10.1002/ijc.27778. View

10.

Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T . Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis. 2012; 33(7):1319-26. DOI: 10.1093/carcin/bgs187. View

11.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

12.

Krishnan A, Swami S, Feldman D . The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids. 2012; 77(11):1107-12. PMC: 3429709. DOI: 10.1016/j.steroids.2012.06.005. View

13.

Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L . Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2009; 18(10):2655-60. DOI: 10.1158/1055-9965.EPI-09-0531. View

14.

McCullough M, Stevens V, Patel R, Jacobs E, Bain E, Horst R . Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res. 2009; 11(4):R64. PMC: 2750126. DOI: 10.1186/bcr2356. View

15.

Robsahm T, Tretli S, Dahlback A, Moan J . Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004; 15(2):149-58. DOI: 10.1023/B:CACO.0000019494.34403.09. View

16.

Moukayed M, Grant W . Molecular link between vitamin D and cancer prevention. Nutrients. 2013; 5(10):3993-4021. PMC: 3820056. DOI: 10.3390/nu5103993. View

17.

Wang D, Velez de-la-Paz O, Zhai J, Liu D . Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. Tumour Biol. 2013; 34(6):3509-17. DOI: 10.1007/s13277-013-0929-2. View

18.

Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault M, Clavel-Chapelon F . Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev. 2010; 20(1):187-98. DOI: 10.1158/1055-9965.EPI-10-1039. View

19.

Lopes N, Paredes J, Costa J, Ylstra B, Schmitt F . Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast Cancer Res. 2012; 14(3):211. PMC: 3446331. DOI: 10.1186/bcr3178. View

20.

Moreno J, Krishnan A, Swami S, Nonn L, Peehl D, Feldman D . Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 2005; 65(17):7917-25. DOI: 10.1158/0008-5472.CAN-05-1435. View